Steve Howard

Abstract PR02: LEE011: An orally bioavailable, selective small molecule inhibitor of CDK4/6– Reactivating Rb in cancer.

Sunkyu Kim, Alice Loo, Rajiv Chopra et al. · Molecular Cancer Therapeutics · 2013 · 104 citations

Medicine, Oncology, Pharmacology +17

Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525

Wenyin Shi, Molly Scannell Bryan, Mark R. Gilbert et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 68 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Initial results from Harvard all-sky optical SETI

Andrew W. Howard, Paul Horowitz, Curtis Mead et al. · Acta Astronautica · 2007 · 60 citations

Natural Sciences, Astronomy, Physics +11

Increasing Access to Clinical Cancer Trials and Emerging Technologies for Minority Populations: The Native American Project

Daniel G. Petereit, Deborah Rogers, Frank S. Govern et al. · Journal of Clinical Oncology · 2004 · 50 citations · Full text

Humanities, Ethnic Studies, Oncology +17

Walking Forward: The South Dakota Native American Project

Daniel G. Petereit, Deborah Rogers, Linda Burhansstipanov et al. · Journal of Cancer Education · 2005 · 34 citations

Humanities, Anthropology, Area Studies +6